drugset / Trial / NCT04723134

Evaluation of a Folic Acid Wound Treatment (FAWT) for Chronic, Early-Stage Diabetic Foot Ulcer (DFU) Healing

NCT04723134 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a twelve-week single-center, randomized, double-blind, clinical study to evaluate the safety and efficacy of a folic acid wound treatment (FAWT) versus Placebo in the promotion of healing of chronic, early stage diabetic foot ulcer (ES-DFU) wounds. Male and female Veterans with type-2 diabetes mellitus and chronic ES-DFUs acceptable to the study inclusion/exclusion criteria will be considered for enrollment.

Timeline

Start
2021-12-01
Primary completion
2024-09-24
Completion
2024-09-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 2.5 % Topical

Indications